Global Biosimilars Sales Market Report 2017

Global Biosimilars Sales Market Report 2017

1 Biosimilars Market Overview

1.1 Product Overview and Scope of Biosimilars

1.2 Classification of Biosimilars by Product Category

1.2.1 Global Biosimilars Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)

1.2.5 Peptides (Glucagon, Calcitonin)

1.3 Global Biosimilars Market by Application/End Users

1.3.1 Global Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Blood Disorders

1.4 Global Biosimilars Market by Region

1.4.1 Global Biosimilars Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States Biosimilars Status and Prospect (2012-2022)

1.4.3 China Biosimilars Status and Prospect (2012-2022)

1.4.4 Europe Biosimilars Status and Prospect (2012-2022)

1.4.5 Japan Biosimilars Status and Prospect (2012-2022)

1.4.6 Southeast Asia Biosimilars Status and Prospect (2012-2022)

1.4.7 India Biosimilars Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Biosimilars (2012-2022)

1.5.1 Global Biosimilars Sales and Growth Rate (2012-2022)

1.5.2 Global Biosimilars Revenue and Growth Rate (2012-2022)

2 Global Biosimilars Competition by Players/Suppliers, Type and Application

2.1 Global Biosimilars Market Competition by Players/Suppliers

2.1.1 Global Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global Biosimilars Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global Biosimilars (Volume and Value) by Type

2.2.1 Global Biosimilars Sales and Market Share by Type (2012-2017)

2.2.2 Global Biosimilars Revenue and Market Share by Type (2012-2017)

2.3 Global Biosimilars (Volume and Value) by Region

2.3.1 Global Biosimilars Sales and Market Share by Region (2012-2017)

2.3.2 Global Biosimilars Revenue and Market Share by Region (2012-2017)

2.4 Global Biosimilars (Volume) by Application

3 United States Biosimilars (Volume, Value and Sales Price)

3.1 United States Biosimilars Sales and Value (2012-2017)

3.1.1 United States Biosimilars Sales and Growth Rate (2012-2017)

3.1.2 United States Biosimilars Revenue and Growth Rate (2012-2017)

3.1.3 United States Biosimilars Sales Price Trend (2012-2017)

3.2 United States Biosimilars Sales Volume and Market Share by Players

3.3 United States Biosimilars Sales Volume and Market Share by Type

3.4 United States Biosimilars Sales Volume and Market Share by Application

4 China Biosimilars (Volume, Value and Sales Price)

4.1 China Biosimilars Sales and Value (2012-2017)

4.1.1 China Biosimilars Sales and Growth Rate (2012-2017)

4.1.2 China Biosimilars Revenue and Growth Rate (2012-2017)

4.1.3 China Biosimilars Sales Price Trend (2012-2017)

4.2 China Biosimilars Sales Volume and Market Share by Players

4.3 China Biosimilars Sales Volume and Market Share by Type

4.4 China Biosimilars Sales Volume and Market Share by Application

5 Europe Biosimilars (Volume, Value and Sales Price)

5.1 Europe Biosimilars Sales and Value (2012-2017)

5.1.1 Europe Biosimilars Sales and Growth Rate (2012-2017)

5.1.2 Europe Biosimilars Revenue and Growth Rate (2012-2017)

5.1.3 Europe Biosimilars Sales Price Trend (2012-2017)

5.2 Europe Biosimilars Sales Volume and Market Share by Players

5.3 Europe Biosimilars Sales Volume and Market Share by Type

5.4 Europe Biosimilars Sales Volume and Market Share by Application

6 Japan Biosimilars (Volume, Value and Sales Price)

6.1 Japan Biosimilars Sales and Value (2012-2017)

6.1.1 Japan Biosimilars Sales and Growth Rate (2012-2017)

6.1.2 Japan Biosimilars Revenue and Growth Rate (2012-2017)

6.1.3 Japan Biosimilars Sales Price Trend (2012-2017)

6.2 Japan Biosimilars Sales Volume and Market Share by Players

6.3 Japan Biosimilars Sales Volume and Market Share by Type

6.4 Japan Biosimilars Sales Volume and Market Share by Application

7 Southeast Asia Biosimilars (Volume, Value and Sales Price)

7.1 Southeast Asia Biosimilars Sales and Value (2012-2017)

7.1.1 Southeast Asia Biosimilars Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Biosimilars Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Biosimilars Sales Price Trend (2012-2017)

7.2 Southeast Asia Biosimilars Sales Volume and Market Share by Players

7.3 Southeast Asia Biosimilars Sales Volume and Market Share by Type

7.4 Southeast Asia Biosimilars Sales Volume and Market Share by Application

8 India Biosimilars (Volume, Value and Sales Price)

8.1 India Biosimilars Sales and Value (2012-2017)

8.1.1 India Biosimilars Sales and Growth Rate (2012-2017)

8.1.2 India Biosimilars Revenue and Growth Rate (2012-2017)

8.1.3 India Biosimilars Sales Price Trend (2012-2017)

8.2 India Biosimilars Sales Volume and Market Share by Players

8.3 India Biosimilars Sales Volume and Market Share by Type

8.4 India Biosimilars Sales Volume and Market Share by Application

9 Global Biosimilars Players/Suppliers Profiles and Sales Data

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Biosimilars Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Sandoz International GmbH

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Biosimilars Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Sandoz International GmbH Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Teva Pharmaceuticals Industries

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Biosimilars Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Amgen Inc

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Biosimilars Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Amgen Inc Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Biocon

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Biosimilars Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Dr. Reddy’s Laboratories

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Biosimilars Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 F. Hoffmann-La Roche

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Biosimilars Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 F. Hoffmann-La Roche Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Celltrion

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Biosimilars Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Samsung Bioepis

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Biosimilars Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Samsung Bioepis Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

10 Biosimilars Maufacturing Cost Analysis

10.1 Biosimilars Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Biosimilars

10.3 Manufacturing Process Analysis of Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Biosimilars Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Biosimilars Market Forecast (2017-2022)

14.1 Global Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Biosimilars Price and Trend Forecast (2017-2022)

14.2 Global Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global Biosimilars Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global Biosimilars Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Biosimilars Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global Biosimilars Sales Forecast by Type (2017-2022)

14.3.2 Global Biosimilars Revenue Forecast by Type (2017-2022)

14.3.3 Global Biosimilars Price Forecast by Type (2017-2022)

14.4 Global Biosimilars Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

Figure Product Picture of Biosimilars

Figure Global Biosimilars Sales Volume Comparison (K MT) by Type (2012-2022)

Figure Global Biosimilars Sales Volume Market Share by Type (Product Category) in 2016

Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture

Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture

Figure Peptides (Glucagon, Calcitonin) Product Picture

Figure Global Biosimilars Sales Comparison (K MT) by Application (2012-2022)

Figure Global Sales Market Share of Biosimilars by Application in 2016

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Blood Disorders Examples

Table Key Downstream Customer in Blood Disorders

Figure Global Biosimilars Market Size (Million USD) by Regions (2012-2022)

Figure United States Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Biosimilars Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Global Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players Biosimilars Sales Volume (K MT) (2012-2017)

Table Global Biosimilars Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Global Biosimilars Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Biosimilars Sales Share by Players/Suppliers

Figure 2017 Biosimilars Sales Share by Players/Suppliers

Figure Global Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Biosimilars Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global Biosimilars Revenue Share by Players

Table 2017 Global Biosimilars Revenue Share by Players

Table Global Biosimilars Sales (K MT) and Market Share by Type (2012-2017)

Table Global Biosimilars Sales Share (K MT) by Type (2012-2017)

Figure Sales Market Share of Biosimilars by Type (2012-2017)

Figure Global Biosimilars Sales Growth Rate by Type (2012-2017)

Table Global Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global Biosimilars Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Biosimilars by Type (2012-2017)

Figure Global Biosimilars Revenue Growth Rate by Type (2012-2017)

Table Global Biosimilars Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Global Biosimilars Sales Share by Region (2012-2017)

Figure Sales Market Share of Biosimilars by Region (2012-2017)

Figure Global Biosimilars Sales Growth Rate by Region in 2016

Table Global Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Biosimilars Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Biosimilars by Region (2012-2017)

Figure Global Biosimilars Revenue Growth Rate by Region in 2016

Table Global Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Biosimilars Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Biosimilars by Region (2012-2017)

Figure Global Biosimilars Revenue Market Share by Region in 2016

Table Global Biosimilars Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Global Biosimilars Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of Biosimilars by Application (2012-2017)

Figure Global Biosimilars Sales Market Share by Application (2012-2017)

Figure United States Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure United States Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table United States Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table United States Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure United States Biosimilars Sales Volume Market Share by Players in 2016

Table United States Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table United States Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure United States Biosimilars Sales Volume Market Share by Type in 2016

Table United States Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table United States Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure United States Biosimilars Sales Volume Market Share by Application in 2016

Figure China Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table China Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table China Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure China Biosimilars Sales Volume Market Share by Players in 2016

Table China Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table China Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure China Biosimilars Sales Volume Market Share by Type in 2016

Table China Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table China Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure China Biosimilars Sales Volume Market Share by Application in 2016

Figure Europe Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure Europe Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table Europe Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table Europe Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure Europe Biosimilars Sales Volume Market Share by Players in 2016

Table Europe Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table Europe Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure Europe Biosimilars Sales Volume Market Share by Type in 2016

Table Europe Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table Europe Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure Europe Biosimilars Sales Volume Market Share by Application in 2016

Figure Japan Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table Japan Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table Japan Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure Japan Biosimilars Sales Volume Market Share by Players in 2016

Table Japan Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table Japan Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure Japan Biosimilars Sales Volume Market Share by Type in 2016

Table Japan Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table Japan Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure Japan Biosimilars Sales Volume Market Share by Application in 2016

Figure Southeast Asia Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table Southeast Asia Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia Biosimilars Sales Volume Market Share by Players in 2016

Table Southeast Asia Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Biosimilars Sales Volume Market Share by Type in 2016

Table Southeast Asia Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table Southeast Asia Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Biosimilars Sales Volume Market Share by Application in 2016

Figure India Biosimilars Sales (K MT) and Growth Rate (2012-2017)

Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Biosimilars Sales Price (USD/MT) Trend (2012-2017)

Table India Biosimilars Sales Volume (K MT) by Players (2012-2017)

Table India Biosimilars Sales Volume Market Share by Players (2012-2017)

Figure India Biosimilars Sales Volume Market Share by Players in 2016

Table India Biosimilars Sales Volume (K MT) by Type (2012-2017)

Table India Biosimilars Sales Volume Market Share by Type (2012-2017)

Figure India Biosimilars Sales Volume Market Share by Type in 2016

Table India Biosimilars Sales Volume (K MT) by Application (2012-2017)

Table India Biosimilars Sales Volume Market Share by Application (2012-2017)

Figure India Biosimilars Sales Volume Market Share by Application in 2016

Table Pfizer Basic Information List

Table Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer Biosimilars Sales Growth Rate (2012-2017)

Figure Pfizer Biosimilars Sales Global Market Share (2012-2017

Figure Pfizer Biosimilars Revenue Global Market Share (2012-2017)

Table Sandoz International GmbH Basic Information List

Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sandoz International GmbH Biosimilars Sales Growth Rate (2012-2017)

Figure Sandoz International GmbH Biosimilars Sales Global Market Share (2012-2017

Figure Sandoz International GmbH Biosimilars Revenue Global Market Share (2012-2017)

Table Teva Pharmaceuticals Industries Basic Information List

Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Teva Pharmaceuticals Industries Biosimilars Sales Growth Rate (2012-2017)

Figure Teva Pharmaceuticals Industries Biosimilars Sales Global Market Share (2012-2017

Figure Teva Pharmaceuticals Industries Biosimilars Revenue Global Market Share (2012-2017)

Table Amgen Inc Basic Information List

Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Amgen Inc Biosimilars Sales Growth Rate (2012-2017)

Figure Amgen Inc Biosimilars Sales Global Market Share (2012-2017

Figure Amgen Inc Biosimilars Revenue Global Market Share (2012-2017)

Table Biocon Basic Information List

Table Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Biocon Biosimilars Sales Growth Rate (2012-2017)

Figure Biocon Biosimilars Sales Global Market Share (2012-2017

Figure Biocon Biosimilars Revenue Global Market Share (2012-2017)

Table Dr. Reddy’s Laboratories Basic Information List

Table Dr. Reddy’s Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Dr. Reddy’s Laboratories Biosimilars Sales Growth Rate (2012-2017)

Figure Dr. Reddy’s Laboratories Biosimilars Sales Global Market Share (2012-2017

Figure Dr. Reddy’s Laboratories Biosimilars Revenue Global Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure F. Hoffmann-La Roche Biosimilars Sales Growth Rate (2012-2017)

Figure F. Hoffmann-La Roche Biosimilars Sales Global Market Share (2012-2017

Figure F. Hoffmann-La Roche Biosimilars Revenue Global Market Share (2012-2017)

Table Celltrion Basic Information List

Table Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Celltrion Biosimilars Sales Growth Rate (2012-2017)

Figure Celltrion Biosimilars Sales Global Market Share (2012-2017

Figure Celltrion Biosimilars Revenue Global Market Share (2012-2017)

Table Samsung Bioepis Basic Information List

Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Samsung Bioepis Biosimilars Sales Growth Rate (2012-2017)

Figure Samsung Bioepis Biosimilars Sales Global Market Share (2012-2017

Figure Samsung Bioepis Biosimilars Revenue Global Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilars

Figure Manufacturing Process Analysis of Biosimilars

Figure Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biosimilars Major Players in 2016

Table Major Buyers of Biosimilars

Table Distributors/Traders List

Figure Global Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Global Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)

Table Global Biosimilars Sales Volume (K MT) Forecast by Regions (2017-2022)

Figure Global Biosimilars Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global Biosimilars Sales Volume Market Share Forecast by Regions in 2022

Table Global Biosimilars Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global Biosimilars Revenue Market Share Forecast by Regions (2017-2022)

Figure Global Biosimilars Revenue Market Share Forecast by Regions in 2022

Figure United States Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure China Biosimilars Revenue and Growth Rate Forecast (2017-2022)

Figure Europe Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Europe Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure India Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global Biosimilars Sales (K MT) Forecast by Type (2017-2022)

Figure Global Biosimilars Sales Volume Market Share Forecast by Type (2017-2022)

Table Global Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Biosimilars Revenue Market Share Forecast by Type (2017-2022)

Table Global Biosimilars Price (USD/MT) Forecast by Type (2017-2022)

Table Global Biosimilars Sales (K MT) Forecast by Application (2017-2022)

Figure Global Biosimilars Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources